136 JOURNAL OF CHEMICAL RESEARCH 2018
66.1, 58.8, 20.9; HRMS calcd for C13H12O+: [M+]: 184.0888; found:
184.0875.
of green and sustainable chemistry. No copper is retained in
the support.
1-Methoxy-4-(phenylbuta-1,3-diynyl)benzene (3d): White solid;
m.p. 85–87 °C (lit.36 86–89 °C); 1H NMR (400 MHz, CDCl3): δ
7.54–7.50 (m, 2H), 7.48–7.44 (m, 2H), 7.36–7.30 (m, 3H), 6.88–6.84
(m, 2H), 3.82 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 160.4, 134.1,
132.4, 129.0, 128.4, 122.1, 114.2, 113.8, 81.9, 81.0, 74.2, 72.8, 55.3.
1-Bromo-4-(phenylbuta-1,3-diynyl)benzene (3e): White solid;
In summary, we have developed a novel, efficient and
practical method for the synthesis of unsymmetrical 1,3-diynes
through the cross-coupling of 1-bromoalkynes with terminal
alkynes by using an MCM-41-immobilised bidentate phosphine
palladium(0) complex [MCM-41-2P-Pd(0)] as the catalyst in
the presence of CuI as a cocatalyst. The reactions generated
a variety of unsymmetrical 1,3-diynes in moderate to good
yields under mild conditions and were applicable to various
1-bromoalkynes and terminal alkynes. In addition, this
methodology offers the competitiveness of recyclability of the
palladium catalyst without significant loss of catalytic activity
and the catalyst could be easily recovered and reused at least
seven times, thus making this procedure economically and
environmentally more acceptable.
1
m.p. 142–144 °C (lit.36 143–145 °C); H NMR (300 MHz, CDCl3): δ
7.54–7.50 (m, 2H), 7.48–7.44 (m, 2H), 7.39–7.31 (m, 5H); 13C NMR (75
MHz, CDCl3): δ 134.1, 132.9, 132.1, 129.6, 128.8, 123.8, 121.9, 121.1,
82.6, 80.7, 75.3, 74.1.
Nona-1,3-diynylbenzene (3f):24 Light yellow oil; 1H NMR (300 MHz,
CDCl3): δ 7.48 (d, J = 7.2 Hz, 2H), 7.36–7.31 (m, 3H), 2.36 (t, J = 7.0
Hz, 2H), 1.61–1.57 (m, 2H), 1.43–1.34 (m, 4H), 0.93 (t, J = 7.0 Hz, 3H);
13C NMR (75 MHz, CDCl3): δ 132.8, 129.2, 128.6, 122.5, 85.3, 75.1,
74.7, 65.4, 31.3, 28.3, 22.5, 19.9, 14.2.
1-Hexyl-4-(4-ethoxyphenyl)buta-1,3-diyne (3g): Light yellow oil;
1H NMR (400 MHz, CDCl3): δ 7.39 (d, J = 8.8 Hz, 2H), 6.80 (d, J = 8.8
Hz, 2H), 4.03 (q, J = 6.8 Hz, 2H), 2.34 (t, J = 7.0 Hz, 2H), 1.59–1.26 (m,
11H), 0.90 (t, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 159.4,
134.0, 114.5, 113.9, 84.2, 74.9, 73.1, 65.2, 63.6, 31.3, 28.6, 28.3, 22.5, 19.6,
14.7, 14.1; HRMS calcd for C18H22O+: [M+]: 254.1671; found: 254.1662.
1-Hexyl-4-(4-methoxyphenyl)buta-1,3-diyne (3h): Light yellow
Experimental
All chemicals were obtained from commercial suppliers and used as
received, unless otherwise noted. All products were characterised by
comparison of their spectra and physical data with the literature where
1
possible. H NMR spectra were recorded on a Bruker Avance 400
(400 MHz) spectrometer with TMS as an internal standard in CDCl3
as solvent. 13C NMR spectra were recorded on a Bruker Avance 400
(100 MHz) spectrometer in CDCl3 as solvent. HRMS spectra were
recorded on a quadrupole-time–of-flight Bruker MicroTOF-Q II mass
spectrometer equipped with an ESI and APCI source. The MCM-41-
2P-Pd(0) complex was prepared according to our previous procedure;34
the palladium content was determined to be 0.45 mmol g–1 by ICP-
AES. 1-Bromoalkynes were prepared by the reaction of terminal
alkynes with NBS in the presence of 1,8-diazabicyclo[5.4.0]undec-7-
ene according to a literature method.35
1
oil; H NMR (400 MHz, CDCl3): δ 7.41 (d, J = 7.2 Hz, 2H), 6.82 (d,
J = 7.6 Hz, 2H), 3.81 (s, 3H), 2.35 (t, J = 6.8 Hz, 2H), 1.59–1.52 (m,
2H), 1.44–1.37 (m, 2H), 1.34–1.20 (m, 4H), 0.90 (t, J = 6.2 Hz, 3H);
13C NMR (100 MHz, CDCl3): δ 160.0, 134.1, 114.0, 112.6, 84.3, 74.8,
73.1, 65.2, 55.3, 31.3, 28.6, 28.3, 22.5, 19.6, 14.1; HRMS calcd for
C17H20O+: [M+]: 240.1514; found: 240.1508.
1-Hexyl-4-(4-ethylphenyl)buta-1,3-diyne (3i): Light yellow oil;
1H NMR (400 MHz, CDCl3): δ 7.39 (d, J = 8.0 Hz, 2H), 7.13 (d, J =
8.0 Hz, 2H), 3.81 (s, 3H), 2.64 (q, J = 7.6 Hz, 2H), 2.35 (t, J = 7.0 Hz,
2H), 1.59–1.54 (m, 2H), 1.44–1.39 (m, 2H), 1.36–1.19 (m, 7H), 0.90 (t,
J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 145.4, 132.5, 128.0,
119.2, 84.5, 75.0, 73.7, 65.1, 31.3, 28.9, 28.6, 28.3, 22.6, 19.6, 15.3, 14.1;
HRMS calcd for C18H22+: [M+]: 238.1722; found: 238.1734.
1-Bromo-4-(nona-1,3-diynyl)benzene (3j):24 Light yellow oil;
1H NMR (300 MHz, CDCl3): δ 7.35 (d, J = 7.8 Hz, 2H), 7.24 (d, J = 8.0
Hz, 2H), 2.27 (t, J = 7.0 Hz, 2H), 1.51–1.47 (m, 2H), 1.32–1.21 (m, 4H),
0.83 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 134.2, 131.8,
123.4, 121.3, 85.8, 75.9, 73.7, 65.3, 31.3, 28.3, 22.5, 19.9, 14.1.
Deca-2,4-diynyl acetate (3k):24 Light yellow oil; 1H NMR (300
MHz, CDCl3): δ 4.68 (s, 2H), 2.25–2.21 (m, 2H), 2.05 (s, 3H),
1.52–1.47 (m, 2H), 1.35–1.26 (m, 4H), 0.87–0.84 (m, 3H); 13C NMR
(75 MHz, CDCl3): δ 170.2, 82.4, 71.8, 69.4, 64.5, 52.7, 31.2, 28.1, 22.4,
20.9, 19.4, 14.1.
Trideca-5,7-diyne (3l):24 Light yellow oil; 1H NMR (300 MHz,
CDCl3): δ 2.24–2.20 (m, 4H), 1.51–1.44 (m, 4H), 1.37–1.28 (m, 6H),
0.91–0.85 (m, 6H); 13C NMR (75 MHz, CDCl3): δ 77.7, 65.4, 31.3, 30.6,
28.3, 22.5, 22.1, 19.4, 19.1, 14.2, 13.9.
CAUTION: Stringent safety precautions are required in
the preparation of MCM-41-2P-Pd(0) when using hydrazine
hydrate as it is highly toxic and harmful to health.
Heterogeneous Pd(0)-catalysed cross-coupling of 1-bromoalkynes
with terminal alkynes; general procedure
A 25 mL round-bottomed flask equipped with a magnetic stirring
bar was charged with 1-bromoalkyne 1 (1.0 mmol), terminal alkyne
2 (1.5 mmol), Et3N (2 mmol), MCM-41-2P-Pd(0) (0.05 mmol), CuI
(0.02 mmol) and DMF (2 mL) under Ar. The resulting mixture was
stirred at room temperature for 12 h. After completion of the reaction,
the mixture was diluted with ethyl acetate (20 mL) and filtered. The
catalyst was washed with distilled water (5 mL) and EtOH (2 × 5 mL)
and could be reused in the next run. The filtrate was washed with
aqueous 25% NH3, which removed any CuI, and brine. It was then
dried over MgSO4. After removal of the solvent under reduced
pressure, the residue was purified by flash column chromatography on
silica gel using a mixture of petroleum ether (boiling range 60-90 ºC)
and EtOAc as eluent.
2-Methyl-6-phenylhexa-3,5-diyn-2-ol (3a): White solid; m.p. 59–61
°C (lit.24 57–59 °C); 1H NMR (400 MHz, CDCl3): δ 7.51–7.49 (m, 2H),
7.37–7.33 (m, 3H), 2.03 (br, 1H), 1.60 (s, 6H); 13C NMR (100 MHz,
CDCl3): δ 132.6, 129.3, 128.5, 121.5, 86.7, 78.8, 73.2, 67.1, 65.8, 31.1.
6-Phenylhexa-3,5-diyn-1-ol (3b): Colourless oil; 1H NMR
(400 MHz, CDCl3): δ 7.48 (d, J = 6.4 Hz, 2H), 7.38–7.30 (m, 3H), 3.81
(t, J = 6.2 Hz, 2H), 2.65 (t, J = 6.2 Hz, 2H), 1.82 (s, 1H); 13C NMR
(100 MHz, CDCl3): δ 132.6, 129.1, 128.4, 121.7, 81.0, 75.4, 74.0,
66.9, 60.8, 24.0; HRMS calcd for C12H10O+: [M+]: 170.0732; found:
170.0737.
2-Methyl-6-(4-ethylphenyl)hexa-3,5-diyne-2-ol (3m): Light yellow
1
oil; H NMR (400 MHz, CDCl3): δ 7.40 (d, J = 7.2 Hz, 2H), 7.15 (d,
J = 7.0 Hz, 2H), 2.65 (q, J = 7.0 Hz, 2H), 2.11 (br, 1H), 1.58 (s, 6H),
1.22 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 145.9, 132.6,
128.1, 118.6, 86.4, 79.2, 72.5, 67.2, 65.8, 31.2, 28.9, 15.3; HRMS calcd
for C15H16O+: [M+]: 212.1201; found: 212.1192.
2-Methyl-6-(3-fluorophenyl)hexa-3,5-diyne-2-ol (3n): Light yellow
1
oil; H NMR (400 MHz, CDCl3): δ 7.32–7.23 (m, 2H), 7.19–7.14 (m,
1H), 7.10–7.01 (m, 1H), 2.01 (br, 1H), 1.59 (s, 6H); 13C NMR (100
MHz, CDCl3): δ 162.2 (d, 1JC–F = 246.0 Hz), 130.1 (d, 3JC–F = 9.0 Hz),
128.4 (d, 4JC–F = 2.0 Hz), 123.4 (d, 3JC–F = 10.0 Hz), 119.2 (d, 2JC–F = 23.0
Hz), 116.8 (d, 2JC–F = 21.0 Hz), 87.3, 77.3, 74.0, 66.8, 65.8, 31.1; HRMS
calcd for C13H11FO+: [M+]: 202.0794; found 202.0788.
1
(6-Methoxyhexa-1,3-diynyl)benzene (3c): Colourless oil; H NMR
2-Methyl-6-(4-ethoxyphenyl)hexa-3,5-diyne-2-ol (3o): Light yellow
1
(400 MHz, CDCl3): δ 7.48–7.45 (m, 2H), 7.37–7.27 (m, 3H), 3.56 (t,
J = 6.8 Hz, 2H), 3.39 (s, 3H), 2.64 (t, J = 6.8 Hz, 2H); 13C NMR (100
MHz, CDCl3): δ 132.5, 128.9, 128.4, 122.0, 81.1, 75.2, 74.2, 70.2,
oil; H NMR (400 MHz, CDCl3): δ 7.40 (d, J = 7.6 Hz, 2H), 6.82 (d,
J = 7.6 Hz, 2H), 4.02 (q, J = 6.2 Hz, 2H), 2.22 (br, 1H), 1.57 (s, 6H),
1.41 (t, J = 6.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 159.7, 134.1,